NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
13.13
-0.43 (-3.17%)
Mar 19, 2026, 4:00 PM EDT - Market closed
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $442.05 million as of March 20, 2026. Its market cap has increased by 13.90% in one year.
Market Cap
442.05M
Enterprise Value
451.83M
1-Year Change
13.90%
Ranking
Category
Stock Price
$13.13
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $442.05M, an increase of 12.40%. That is a compound annual growth rate of 2.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 456.52M | -11.23% |
| Dec 31, 2025 | 514.27M | 53.97% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | 393.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Axogen | 567.87M |
| SI-BONE | 567.08M |
| Perspective Therapeutics | 563.97M |
| Cytek Biosciences | 546.34M |
| Orthofix Medical | 482.94M |
| Varex Imaging | 475.15M |
| Beta Bionics | 472.23M |
| OrthoPediatrics | 435.05M |